These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29309358)

  • 1. Topical Tacrolimus 0.03% for Maintenance Therapy in Steroid-Dependent, Recurrent Phlyctenular Keratoconjunctivitis.
    Yoon CH; Kim MK; Oh JY
    Cornea; 2018 Feb; 37(2):168-171. PubMed ID: 29309358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
    Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment.
    Kymionis GD; Klados NE; Kontadakis GA; Mikropoulos DG
    Cornea; 2013 Nov; 32(11):1499-501. PubMed ID: 23770977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
    Ghanem RC; Vargas JF; Ghanem VC
    Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus ointment in the management of atopic keratoconjunctivitis.
    Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J
    J Fr Ophtalmol; 2019 Apr; 42(4):e147-e151. PubMed ID: 30851973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
    Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
    Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus.
    Hirota A; Shoji J; Inada N; Shiraki Y; Yamagami S
    Cornea; 2022 Jan; 41(1):23-30. PubMed ID: 34870621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.
    Müller GG; José NK; de Castro RS; de Holanda EC
    Arq Bras Oftalmol; 2019; 82(2):119-123. PubMed ID: 30698232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Trivizki O; Shachar Y; Levinger S; Verssano D
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):811-6. PubMed ID: 24696044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases.
    Lee YJ; Kim SW; Seo KY
    Am J Ophthalmol; 2013 May; 155(5):804-13. PubMed ID: 23394907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tacrolimus ointment in the management of atopic keratoconjunctivitis].
    Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J
    J Fr Ophtalmol; 2019 May; 42(5):435-440. PubMed ID: 30935698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis.
    Arici C; Mergen B
    Br J Ophthalmol; 2021 May; 105(5):614-618. PubMed ID: 32563992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH; Kim JM; Laddha PM; Chung ES; Chung TY
    Korean J Ophthalmol; 2012 Aug; 26(4):241-7. PubMed ID: 22870021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option?
    Westland T; de Bruin-Weller MS; Van der Lelij A
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1187-9. PubMed ID: 23106347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.